Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 43,181Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211135

FDA
01 Sep 2022

https://www.businesswire.com/news/home/20210329005176/en

BUSINESSWIRE
29 Mar 2021

https://www.businesswire.com/news/home/20210329005176/en/Bayer-Announces-Publication-of-Phase-IV-Adempas%C2%AE-riociguat-Data-in-The-Lancet-Respiratory-Medicine

BUSINESSWIRE
29 Mar 2021

https://www.firstwordpharma.com/node/1766758?tsid=3

FIRSTWORDPHARMA
20 Oct 2020

https://www.biospace.com/article/releases/bayer-phase-iv-study-met-its-primary-endpoint-in-pah-patients-who-had-transitioned-to-adempas-riociguat-after-insufficient-response-to-pde5-inhibitors-/

BIOSPACE
07 Sep 2020
Adempas maker Bayer launches new hypertension support group
Adempas maker Bayer launches new hypertension support group

14 Jul 2018

// Carly Helfand FIERCE PHARMA

https://www.fiercepharma.com/marketing/adempas-maker-bayer-connects-hypertension-patients-new-mentoring-group

Carly Helfand FIERCE PHARMA
14 Jul 2018